AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimihop M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Anax Lifescience

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimihop M 1mg/500mg Tablet

Diabex Duo 1mg/500mg tablets are classified as antidiabetic medications, combining two drugs to manage type 2 diabetes in adults. This medication helps regulate blood glucose in diabetic patients. Diabex Duo should be administered with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continue taking this medication even if feeling well or if blood sugar is controlled; discontinuation without consulting your doctor can lead to elevated blood sugar, potentially causing kidney complications, vision loss, nerve damage, and limb loss. Remember, it's crucial to combine this medication with a doctor-recommended diet, regular physical activity, and weight management – lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Learn to recognize and treat these symptoms; maintain regular mealtimes and carry a fast-acting glucose source like sugary snacks or juice. Alcohol increases hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections; weight gain may occur. This medication is unsuitable for type 1 diabetes, diabetic ketoacidosis, or severe kidney/liver disease. Inform your doctor of any history of heart disease before starting treatment, as it may be inappropriate. Pregnant or breastfeeding women should consult their physician prior to use. Regular blood sugar monitoring, along with potential blood tests for cell counts and liver function, will be recommended by your doctor.

Uses of Glimihop M 1mg/500mg Tablet

Managing Type 2 Diabetes

Major Benefits of Glimihop M 1mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimihop M 1mg/500mg Tablet whole; do not crush, chew, or divide it. Administer this medication with a meal.

Common Side effects of Glimihop M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimihop M 1mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Glimihop M 1mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.

How Glimihop M 1mg/500mg Tablet works:

Glimihop M, a 1mg/500mg tablet, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glimihop M 1mg/500mg tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimihop M 1mg/500mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Consult your doctor for advice.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should not take Glimihop M 1mg/500mg tablets; evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimihop M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glimihop M 1mg/500mg tablets. Medical consultation is essential. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimihop M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Medical advice is essential. A low initial dose is typically prescribed for individuals with mild to moderate liver disease; however, its use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Glimihop M 1mg/500mg Tablet :

Should you forget a Glimihop M 1mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimihop M 1mg/500mg Tablet

LabelValue
Potential for Dependence None.
Treatment Category Medication for diabetes

FAQs on Glimihop M 1mg/500mg Tablet

Store the medication in its original, tightly sealed container, following the storage directions provided on the packaging. Discard any remaining medication. Prevent access by children, pets, and others.
Glimihop M 1mg/500mg Tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed metformin-associated lactic acidosis (MALA), this rare but potentially harmful side effect is more likely in individuals with kidney impairment, the elderly, or those who consume significant alcohol. Symptoms such as muscle aches, weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, vomiting, abdominal pain, and bradycardia warrant immediate discontinuation of Glimihop M 1mg/500mg Tablets and prompt medical attention.
Glimihop M 1mg/500mg tablets contain glimepiride and metformin, acting in tandem to manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when combined with a healthy diet and regular physical activity. Glimepiride stimulates insulin secretion from the pancreas, reducing blood glucose. Metformin decreases hepatic glucose production and increases insulin responsiveness. This formulation is unsuitable for type 1 diabetes mellitus.
Glimihop M 1mg/500mg tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste perception, nausea, abdominal pain, diarrhea, and headache. Rare but serious adverse reactions, including lactic acidosis, are also possible. Prolonged use might result in vitamin B12 deficiency.
Prolonged Glimihop M 1mg/500mg Tablet use can indeed lead to Vitamin B12 deficiency. This medication impairs Vitamin B12 absorption in the gastrointestinal tract. Consequently, untreated deficiency may result in anemia, neurological complications, and symptoms such as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and gait instability. Preventive measures, recommended by some studies, include annual supplemental Vitamin B12 intake.
Indeed, Glimihop M 1mg/500mg Tablets can induce hypoglycemia (low blood glucose). Manifestations of low blood sugar encompass nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. The likelihood increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting carbohydrate source, such as glucose tablets, honey, or fruit juice, is recommended.
Consuming alcohol while taking Glimihop M 1mg/500mg tablets is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and heighten the risk of lactic acidosis.
Glimihop M 1mg/500mg Tabl...
52
MRP 63
17% off